William Barclay

31.2k citations

213 papers · 12.1k indexed · 6 hit papers · h-index 57

Impact in

Infectious Diseases top 0.1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
Epidemiology top 0.2%
- Influenza Virus Research Studies
- Respiratory viral infections research

Papers in

Infectious Diseases 78
- SARS-CoV-2 and COVID-19 Research 42
- COVID-19 Clinical Research Studies 29
- Viral gastroenteritis research and epidemiology 21
Modeling and Simulation 18

Co-authors: Jason S. Long Thomas P. Peacock Olivier Moncorgé Bhakti Mistry Maria Zambon Paul Kellam Stuart M. Haslam Holly Shelton
Journals: Journal of Virology (32 papers)Journal of General Virology (21 papers)Nature Communications (13 papers)PLoS Pathogens (9 papers)Virology (8 papers)
Partner nations: United Kingdom United States Netherlands

In The Last Decade

William Barclay

200 papers receiving 11.9k citations

Hit Papers

6 papers align trajectories log scale

SARS-CoV-2 variant biology: immune escape, transmission and fitness 2023 · 682 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Nature Reviews Microbiology
2021 Nature Microbiology
2021 Nature
2018 Nature Reviews Microbiology
2013 Nature
2013 Nature Medicine

Peers

Countries citing papers authored by William Barclay

Since Specialization

Citations

This map shows the geographic impact of William Barclay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Barclay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Barclay more than expected).

Fields of papers citing papers by William Barclay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Barclay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Barclay. The network helps show where William Barclay may publish in the future.

Co-authorship network

The 25 scholars most cited alongside William Barclay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William Barclay Line = papers co-authored together William Barclay links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice Frontiers in Immunology ·Patricia P. Ogger, 昭平長田, FNU Pawan Kumar, Jie Zhou, Jonathan C. Brown, Ksenia Sukhova, Wilhelm Furnon, Arvind H. Patel, Vanessa M. Cowton, Massimo Palmarini, William Barclay, Cecilia Johansson	2024	0
2	Inno4Vac Workshop Report Part 1: Controlled Human Influenza Virus Infection Model (CHIVIM) Strain Selection and Immune Assays for CHIVIM Studies, November 2021, MHRA, UK Influenza and Other Respiratory Viruses ·Joanna Waldock, Rebecca Jane Cox, R. Kuriyarma, Kanta Subbarao, Adrian Wildfire, William Barclay, Puck B. van Kasteren, John W. McCauley, Colin A. Russell, Derek J. Smith, Ryan S. Thwaites, John S. Tregoning, Ignacio García López	2024	0
3	Avian Influenza A Virus Polymerase Can Utilize Human ANP32 Proteins To Support cRNA but Not vRNA Synthesis mBio ·Olivia C. Swann, Gaoqing Ji, Thomas P. Peacock, Carol Sheppard, William Barclay	2023	11
4	An Influenza A virus can evolve to use human ANP32E through altering polymerase dimerization Nature Communications ·Carol Sheppard, Daniel H. Goldhill, Olivia C. Swann, Ecco Staller, Rebecca Penn, Erika Ohue, Ksenia Sukhova, Laury Baillon, Rebecca Frise, Thomas P. Peacock, Ervin Fodor, William Barclay	2023	14
5	Propylene glycol inactivates respiratory viruses and prevents airborne transmission EMBO Molecular Medicine ·Christine T. Styles, Jie Zhou, Katie E. Flight, Jonathan C. Brown, J. R. Philip, شبنم حمزه, G. Palmai, Thomas P. Peacock, Ziyin Wang, 永斌, John S. O’Neill, Alexander Borodavka, Joe Grove, William Barclay, John S. Tregoning, Rachel S. Edgar	2023	5
6	Validity of Self-testing at Home With Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Detection by Lateral Flow Immunoassay Clinical Infectious Diseases ·Christina Atchison, Maya Moshe, Jonathan C. Brown, Matthew Whitaker, 道雄川筋, Anil A. Bharath, Rachel A. McKendry, Ara Darzi, Deborah Ashby, Christl A. Donnelly, Steven Riley, Paul Elliott, William Barclay, Graham Cooke, Helen Ward	2022	9
7	Polymer formulated self-amplifying RNA vaccine is partially protective against influenza virus infection in ferrets PubMed ·Paul F. McKay, Jie Zhou, Rebecca Frise, Anna K. Blakney, Clément R. Bouton, Ziyin Wang, Kai Hu, Karnyart Samnuan, Jonathan C. Brown, Ruthiran Kugathasan, Jonathan Yeow, Molly M. Stevens, William Barclay, John S. Tregoning, Robin J. Shattock	2022	8
8	The C-terminal LCAR of host ANP32 proteins interacts with the influenza A virus nucleoprotein to promote the replication of the viral RNA genome Nucleic Acids Research ·Fangzheng Wang, Carol Sheppard, Bhakti Mistry, Ecco Staller, William Barclay, Jonathan M. Grimes, Ervin Fodor, Haitian Fan	2022	22
9	Population antibody responses following COVID-19 vaccination in 212,102 individuals Nature Communications ·Helen Ward, Matthew Whitaker, Barnaby Flower, Pamela de Santa, Christina Atchison, Ara Darzi, Christl A. Donnelly, Alexandra Cann, Peter J. Diggle, Deborah Ashby, Steven Riley, William Barclay, Paul Elliott, Graham Cooke	2022	90
10	Machine learning to support visual auditing of home-based lateral flow immunoassay self-test results for SARS-CoV-2 antibodies SHILAP Revista de lepidopterología ·道雄川筋, S.L. Rakovitskii, Valérian Turbé, Matthew Whitaker, Maya Moshe, Марина Сергеевна Ермак, Tianhong Dai, John W. Abbott, William Barclay, Ara Darzi, Paul Elliott, Helen Ward, Reiko Tanaka, Graham Cooke, Rachel A. McKendry, Christina Atchison, Anil A. Bharath	2022	22
11	Acceptability, Usability, and Performance of Lateral Flow Immunoassay Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: REACT-2 Study of Self-Testing in Nonhealthcare Key Workers Open Forum Infectious Diseases ·Bethan Davies, Marzieh Araghi, Maya Moshe, He Gao, พนิดา ทรัพยสาร, Hamed Tahmasbi, Christina Atchison, Ara Darzi, Deborah Ashby, Steven Riley, William Barclay, Paul Elliott, Helen Ward, Graham Cooke	2021	13
12	SARS-CoV-2 environmental contamination from hospitalised patients with COVID-19 receiving aerosol-generating procedures Thorax ·M. Sathiyabarathi, Jie Zhou, Luana Malec, Maureen P. Bezold, Ranjit Lall, Chen Ji, Jonathan Millar, Paul Dark, Jay Naisbitt, Anita K. Simonds, Jake Dunning, William Barclay, J. Kenneth Baillie, Gavin D. Perkins, Malcolm G. Semple, Daniel F. McAuley, Christopher Green	2021	26
13	Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination PLoS Pathogens ·Christopher Davis, Nicola Logan, Grace Tyson, Richard Orton, William T. Harvey, Michael Ermakov, Guy Mollett, Rachel Blacow, Thomas P. Peacock, William Barclay, Peter Cherepanov, Massimo Palmarini, Pablo R. Murcia, Arvind H. Patel, David L. Robertson, John Haughney, Emma C. Thomson, Brian J. Willett, (unknown)	2021	117
14	Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia Nature ·Luca Braga, Hashim Ali, Ilaria Secco, Elena Chiavacci, Guilherme Neves, Daniel H. Goldhill, Rebecca Penn, Jose M. Jiménez-Guardeño, Ana Maria Ortega‐Prieto, Rossana Bussani, Antonio Cannatà, Hilda Sharifzadeh, Chiara Collesi, Edoardo Schneider, Daniele Arosio, Ajay M. Shah, William Barclay, Michael H. Malim, Juan Burrone, Mauro Giacca Hit paper breakdown →	2021	281
15	Investigating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Surface and Air Contamination in an Acute Healthcare Setting During the Peak of the Coronavirus Disease 2019 (COVID-19) Pandemic in London Clinical Infectious Diseases ·Jie Zhou, Jonathan A. Otter, James Price, Samuel Lockner, 浦川善美, James Kinross, Piers R. Boshier, Sam Mason, Frances Bolt, Alison Holmes, William Barclay	2020	177
16	Population implications of the deployment of novel universal vaccines against epidemic and pandemic influenza Journal of The Royal Society Interface ·Nimalan Arinaminpathy, Steven Riley, William Barclay, Chadi M. Saad-Roy, Bryan T. Grenfell	2020	11
17	Host ANP32A mediates the assembly of the influenza virus replicase Nature ·Loïc Carrique, Haitian Fan, Alexander P. Walker, J.R. Keown, Jane Sharps, Ecco Staller, William Barclay, Ervin Fodor, Jonathan M. Grimes	2020	107
18	Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission PLoS Pathogens ·Leo Lee, Jie Zhou, Rebecca Frise, Daniel H. Goldhill, Wu MingSen, Edin Mifsud, Jinxiao Zhong, Takahiro Noda, Chaoyang Wang, Kenji Sato, Liu Xi-tai, Takao Shishido, Takeki Uehara, Steffen Wildum, Caroline Cheong, Neil Collinson, Mohammadreza Sinayi, Barry Clinch, Aeron C. Hurt, William Barclay	2020	31
19	Characterising viable virus from air exhaled by H1N1 influenza-infected ferrets reveals the importance of haemagglutinin stability for airborne infectivity PLoS Pathogens ·Anika Singanayagam, Jie Zhou, Ruth A. Elderfield, Rebecca Frise, Jonathan Ashcroft, Mónica Galiano, Shahjahan Miah, Laura Nicolaou, William Barclay	2020	31
20	Viral factors in influenza pandemic risk assessment eLife ·Marc Lipsitch, William Barclay, Rahul Raman, Charles J. Russell, Jessica A. Belser, Sarah Cobey, Peter M. Kasson, James O. Lloyd‐Smith, Sebastian Maurer‐Stroh, Steven Riley, Catherine A. A. Beauchemin, Trevor Bedford, Thomas C. Friedrich, Andreas Handel, Sander Herfst, Pablo R. Murcia, Benjamín Roche, Claus O. Wilke, Colin A. Russell	2016	66

About William Barclay

William Barclay is a scholar working on Infectious Diseases, Modeling and Simulation, Epidemiology, Agronomy and Crop Science and Immunology, having authored 213 papers that have together received 12.1k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (114 papers), Respiratory viral infections research (70 papers), SARS-CoV-2 and COVID-19 Research (42 papers), interferon and immune responses (34 papers), Animal Disease Management and Epidemiology (32 papers), COVID-19 Clinical Research Studies (29 papers), RNA and protein synthesis mechanisms (22 papers) and Viral gastroenteritis research and epidemiology (21 papers). The work is most often cited by research in Infectious Diseases (5.5k citations), Epidemiology (5.8k citations), Modeling and Simulation (704 citations), Immunology (3.2k citations) and Agronomy and Crop Science (1.3k citations). William Barclay has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Jason S. Long, Thomas P. Peacock, Olivier Moncorgé, Bhakti Mistry, Maria Zambon, Paul Kellam, Stuart M. Haslam, Holly Shelton, Daniel H. Goldhill and Rebecca Penn. Their work appears in journals such as Journal of Virology, Journal of General Virology, Nature Communications, PLoS Pathogens and Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact